Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5284950
Max Phase: Preclinical
Molecular Formula: C27H18F12N4OS
Molecular Weight: 674.51
Associated Items:
ID: ALA5284950
Max Phase: Preclinical
Molecular Formula: C27H18F12N4OS
Molecular Weight: 674.51
Associated Items:
Canonical SMILES: CON1c2ccccc2[C@@]2(CN=C(Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)S2)[C@H]1Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1
Standard InChI: InChI=1S/C27H18F12N4OS/c1-44-43-20-5-3-2-4-19(20)23(21(43)41-17-8-13(24(28,29)30)6-14(9-17)25(31,32)33)12-40-22(45-23)42-18-10-15(26(34,35)36)7-16(11-18)27(37,38)39/h2-11,21,41H,12H2,1H3,(H,40,42)/t21-,23-/m0/s1
Standard InChI Key: AYYUSFVUEKRCDG-GMAHTHKFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 674.51 | Molecular Weight (Monoisotopic): 674.1010 | AlogP: 8.99 | #Rotatable Bonds: 4 |
Polar Surface Area: 48.89 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.08 | CX Basic pKa: 5.41 | CX LogP: 9.10 | CX LogD: 9.09 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.27 | Np Likeness Score: -0.43 |
1. Bora D, Kaushal A, Shankaraiah N.. (2021) Anticancer potential of spirocompounds in medicinal chemistry: A pentennial expedition., 215 [PMID:33601313] [10.1016/j.ejmech.2021.113263] |
Source(1):